CEACAM5 and colorectal carcinoma: By combining CEA with other EV‐derived blood biomarkers, the ZAHV‐AI system effectively enhances the diagnostic accuracy for early‐stage CRC, thereby addressing the inherent limitations of CEA as a diagnostic marker and offering a more robust tool for early detection.